On July 12, 2026, researchers at the Broad Institute unveiled a low-cost genome sequencing method called Blended Genome Exome (BGE), significantly advancing the study of mental illness. The innovative approach reduces sequencing costs by 75%, enabling large-scale genetic research essential for uncovering the genetic basis of diseases.
Advancements in Genome Sequencing
The BGE method, developed by scientists at the Stanley Center for Psychiatric Research and Broad Clinical Labs, has been described in a recent paper published in Nature Genetics. Co-senior author Alicia Martin stated, "In this study, we've shown that the BGE technology works and it works at scale, and now the entire field can benefit from the method." This advancement is crucial for researchers aiming to identify genetic markers associated with severe mental illnesses.
Since its introduction in late 2022, the BGE method has already sequenced over 400,000 human DNA samples. In 2025 alone, it accounted for 30% of all genomic specimens processed by Broad Clinical Labs, with nearly 123,000 samples analyzed using this cost-effective method.
Benefits of the BGE Method
The BGE method allows researchers to conduct larger studies and analyze genetic variation in ancestrally diverse populations, accelerating the discovery of genetic factors related to human diseases. The dual scanning process captures both the exome, which contains crucial protein-coding regions, and broader genomic data.
- Cost reduction: Sequencing costs lowered by 75%
- Sample size: Over 400,000 DNA samples sequenced
- Processing speed: Nearly 123,000 samples processed in 2025
Martin emphasized the importance of studying diverse populations to identify new biologies and genetic loci linked with severe mental illnesses. The BGE method has also been adapted for clinical use, facilitating low-cost genetic testing for patients, including those at risk for conditions like prostate cancer.
Future Implications of BGE in Genetic Research
As the BGE method continues to be adopted, it holds the potential to enhance polygenic scores, improving predictions of disease risk, especially in underrepresented groups in genomic research. The synchronized data generation from the genome and exome scans minimizes errors and maximizes the accuracy of genetic analyses.
Martin expressed gratitude towards the research participants, acknowledging their critical role in advancing scientific understanding of psychiatric disorders. The willingness of participants to share their DNA is vital, particularly for conditions that carry social stigma.
"We're incredibly appreciative of their willingness to share their DNA, particularly when many of them have some of these disorders that are pretty stigmatized in different ways around the world," said Martin.
🤖 This article was rewritten by Feed and Figures' editorial AI from a report originally published by Phys.org. Facts and quotes are preserved from the original; the rewrite focuses on clarity and structure. For the unedited original, see the source link below.
